At this moment gloom and doom attitudes are certainly not warranted, but neither are the everything is rosy. As an OTC with loss since inception I don't think this company has ever been in an everything is rosy state. I was just a couple of months from thinking this investment was likely a total loss because they couldn't seem to be able to secure anymore county deals. Nimbo tracking and CUTrack cannot bring in enough income to pay the bills.
Things are still not rosy but we are back to this being an OTC company that in my opinion is worth the risk of investment at this price, for those who can afford to lose all of their investment.
But I do think at this point with the partnership with Prolog we have the potential for a PR that suddenly thrusts us into everything coming up roses at anytime.
News 
Market Data 
Discover 
AI
